OICHARTS
8 AMThe 8 AM report →

INFINIUMInfinium Pharmachem Limited share price

NSE · INE0MRE01011 · 253 sessions on record
₹307.35▼ −4.45 · −1.4%from ₹311.80 the session before · 6 Oct 2026 close · NSE end of day
Open
₹324.50
High
₹324.50
Low
₹306.50
Day's range
₹185.8% of the previous close
VWAP
₹310.28close −0.94% from it
Volume, shares
9,0000.98× the 20-session average
Turnover, ₹ crore
0.28
Trades
16560 shares per trade
Previous close
₹311.80−4.45 to the close
Price band, next session
₹276.60 – ₹338.1010% either side of the close · dynamic, widened in 5% steps when hit
Day range5% of the way up
₹306.50₹324.50
52-week range87% of the way up
₹189.40 30 Mar₹324.50 6 Oct

−5.3% from the high · +62% from the low

Futures and options

No derivatives listed on INFINIUM

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 6 Oct · axis fixed at 4 × ATR-14 around the last close
253 sessions on file · from 11 Sept
INFINIUM close and futures open interest over the last 126 sessions, with Nifty 50 rebased to the first close191.05281.35371.65axis spans 95%Nifty 50INFINIUM1 Apr6 Jul6 Oct126 sessions from 1 Apr to 6 Oct; the price axis spans 95 percent.

Quarterly results

consolidated · latest filed 29 May, 08:02 pm IST · NSE filings

Revenue ₹190 cr; profit ₹12 cr in the Mar 2026 quarter, consolidated.

Last 1 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of INFINIUM on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Mar 2026filed 29 May · audited₹190 cr—₹12 cr—7.80▼ −1.1%Nifty −0.7% · −0.3 pp

Fundamentals

consolidated · filings to Mar 2026 · close ₹307.35 on 6 Oct

Fundamentals for INFINIUM on the consolidated basis to Mar 2026.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
—no NSE market-cap record yet
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
—no balance sheet filed yet
Book value a share
—no equity line in the filing
Debt to equity
—no equity line in the filing
Return on equity
—needs two filed balance sheets
Dividend yield
—no dividend with an ex-date in 365 days
Face value
—no NSE record yet
Shares outstanding
—no NSE record yet
Growthsums of the four quarters filed to Mar 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed

Shareholding

quarter to 30 Sept · none pledged · NSE filings

Promoters hold 64.9%, banks and financial institutions 0.2%, individual investors 32.2% and others 2.6%, as filed for the quarter to 30 Sept.

By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of INFINIUM by category over the last 2 quarters with the change against the previous quarter
Category30 Sept31 Mar
Promoters64.910.00 pp64.91
Banks and financial institutions0.23▲ +0.02 pp0.21
Individual investors32.24▲ +0.14 pp32.10
Bodies corporate0.06▼ −0.07 pp0.13
Others2.56▼ −0.09 pp2.65

Corporate actions

NSE and BSE records

No corporate action on record for INFINIUM yet.

Price history

253 sessions on record · to 6 Oct · NSE end of day

INFINIUM is +16.4% over 20 sessions against Nifty's −4.7%, 5.3% below its 52-week high, realised volatility 61% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹INFINIUM %Nifty 50 %Difference pp
250 sessionssince 15 Sept₹246.00▲ +25%▼ −9.1%+34
120 sessionssince 9 Apr₹219.94▲ +40%▼ −4.2%+44
60 sessionssince 8 Jul₹211.75▲ +45%▼ −4.6%+50
20 sessionssince 4 Sept₹264.00▲ +16%▼ −4.7%+21
5 sessionssince 28 Sept₹268.50▲ +14%−0.02%+14
1 sessionsince 5 Oct₹311.81▼ −1.4%▲ +0.98%−2.4
Averages of the closeclose against each average
5-session average
₹298.27close +3.0% from it
20-session average
₹277.09close +11% from it
50-session average
₹249.63close +23% from it
200-session average
₹222.48close +38% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹165.2% of the close
Average day's range, 20
₹165.1% of the close
Volume against 20 sessions
0.98×9,000 vs 8,900 average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
61%≈ ±3.8% a session · moved more than that on 7 of 20
Realised volatility, 60
56%≈ ±3.5% a session · moved more than that on 15 of 60
Realised volatility, 250
40%≈ ±2.5% a session · moved more than that on 63 of 250
Beta to Nifty, 60
-0.76moved with Nifty on 31 of 60 sessions
Beta to Nifty, 250
0.23moved with Nifty on 130 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
11 up · 9 downof 20
Last 60 sessions
31 up · 29 downof 60
Last 250 sessions
124 up · 117 downof 241
Best session, 250
▲ +10%25 Aug
Worst session, 250
▼ −7.4%19 Aug

0 bulletins on INFINIUM

The desk has not written about Infinium Pharmachem Limited yet. The tape carries every bulletin as it is published.

About Infinium Pharmachem Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
Infinium Pharmachem Limited
Exchange
NSE
ISIN
INE0MRE01011
Sessions on record
253
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
16 Oct, 03:07 am IST
Bulletins
0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.